BiotechTube
Home/Pipeline/CPR‑CYC‑101

CPR‑CYC‑101

Solid Tumors

PreclinicalActive

Key Facts

Indication
Solid Tumors
Phase
Preclinical
Status
Active
Company
Chugai Pharmabody Research

About Chugai Pharmabody Research

CPR pioneers antibody and cyclic peptide drug discovery to address unmet medical needs worldwide.

View full company profile

Therapeutic Areas

OncologyImmunologyHematologyInfectious Disease

Other Solid Tumors Drugs

DrugCompanyPhase
APVO603Aptevo TherapeuticsPreclinical
APVO711Aptevo TherapeuticsPreclinical
Platform-derived ImmunotherapyGenCirqPre-clinical
SP-2-225Shuttle PharmaceuticalsPreclinical
SP-1-161Shuttle PharmaceuticalsPreclinical
CAR-T Solid Tumor ProgramCarina BiotechPhase 1/2a
HBM1020Harbour BioMedPhase 1
HBM7022Harbour BioMedPhase 1
HBM9033Harbour BioMedDiscovery
Undisclosed Whole Cell Vaccine Program(s)NeuvogenPre-clinical
SY-5609Syros PharmaceuticalsPhase 1/2
Not Specified (TCR Therapy)T-Cure BiosciencePhase 1